OTC Pharmaceuticals in Japan

Date: September 27, 2016
Pages: 35
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O3FB8174633EN
Leaflet:

Download PDF Leaflet

OTC Pharmaceuticals in Japan
SUMMARY

OTC Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Japan
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Japan
  • Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Japan otc pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Japan otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Japan otc pharmaceuticals market by value in 2015?
  • What will be the size of the Japan otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Japan otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Japan's otc pharmaceuticals market?
KEY HIGHLIGHTS

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.

The Japanese OTC Pharmaceuticals market generated total revenues of $10,136.7m in 2015, representing a CAGR of 1.4% between 2011 and 2015.

Traditional medicines registered the highest sales value in the Japanese OTC Pharmaceuticals market in 2015, with total sales of $3,581.6m, equivalent to 35.3% of the market's overall value.

Japan spends 11.2% of its GDP on healthcare, a comparatively high figure to the OECD average of 9%.
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Daiichi Sankyo Co., Ltd.
Johnson and Johnson
Kracie Holdings, Ltd.
Novartis AG
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Japan OTC pharmaceuticals market value: $ million, 2011-15
Table 2: Japan OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Japan OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Japan OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Japan OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 7: Daiichi Sankyo Co., Ltd.: key facts
Table 8: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 9: Daiichi Sankyo Co., Ltd.: key financials (¥)
Table 10: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 11: Johnson and Johnson: key facts
Table 12: Johnson and Johnson: key financials ($)
Table 13: Johnson and Johnson: key financial ratios
Table 14: Kracie Holdings, Ltd.: key facts
Table 15: Novartis AG: key facts
Table 16: Novartis AG: key financials ($)
Table 17: Novartis AG: key financial ratios
Table 18: Japan size of population (million), 2011-15
Table 19: Japan gdp (constant 2005 prices, $ billion), 2011-15
Table 20: Japan gdp (current prices, $ billion), 2011-15
Table 21: Japan inflation, 2011-15
Table 22: Japan consumer price index (absolute), 2011-15
Table 23: Japan exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Japan OTC pharmaceuticals market value: $ million, 2011-15
Figure 2: Japan OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Japan OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Japan OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Japan OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Japan, 2015
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Japan, 2015
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Japan, 2015
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Japan, 2015
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Japan, 2015
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Japan, 2015
Figure 13: Daiichi Sankyo Co., Ltd.: revenues and profitability
Figure 14: Daiichi Sankyo Co., Ltd.: assets and liabilities
Figure 15: Johnson and Johnson: revenues and profitability
Figure 16: Johnson and Johnson: assets and liabilities
Figure 17: Novartis AG: revenues and profitability
Figure 18: Novartis AG: assets and liabilities

COMPANIES MENTIONED

Daiichi Sankyo Co., Ltd.
Johnson and Johnson
Kracie Holdings, Ltd.
Novartis AG
Skip to top


OTC Pharmaceuticals Global Industry Guide_2016 US$ 1,495.00 Oct, 2016 · 271 pages
OTC Pharmaceuticals Global Industry Almanac_2016 US$ 2,995.00 Oct, 2016 · 491 pages
OTC Pharmaceuticals in Singapore US$ 350.00 Sep, 2016 · 40 pages
Global OTC Pharmaceuticals US$ 350.00 Sep, 2016 · 38 pages

Ask Your Question

OTC Pharmaceuticals in Japan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: